Global Tacrolimus Market Size, Share & Trends Analysis Report, By Product Type (Tablets & Capsules, Injections, Others), By Application (Immunosuppression, Dermatitis, and Others.), By End-use (Hospitals, Clinics, and Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1005035 | Industries : Healthcare | Published On :January 2024 | Page Count : 201

Global Tacrolimus Market Size, Share & Trends Analysis Report, By Product Type (Tablets & Capsules, Injections, Others), By Application (Immunosuppression, Dermatitis, and Others.), By End-use (Hospitals, Clinics, and Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Tacrolimus market estimated at USD 6484.2 million in 2022 and which expected, at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2030. Key players in the Tacrolimus market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Tacrolimus market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

TACROLIMUS MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Growing Incidence of Dermatological Disorders
The increasing prevalence of dermatological disorders, such as eczema and psoriasis, has been a significant driver for the Tacrolimus market. Tacrolimus, known for its immunosuppressive properties, is widely used in topical formulations to treat these conditions effectively. The rising number of patients seeking treatment for skin disorders has contributed to the expanding market for Tacrolimus-based medications.

Concerns Regarding Long-Term Safety and Side Effects

A notable restraint in the Tacrolimus market is the ongoing concern and scrutiny surrounding its long-term safety and potential side effects. Prolonged use of Tacrolimus, particularly in higher concentrations, has raised questions about adverse effects, including skin atrophy and a theoretical risk of malignancy. These concerns have led to cautious prescribing practices and ongoing research to better understand the safety profile of Tacrolimus over extended periods, impacting its adoption in certain cases.

How are Segments Performing in the Global Tacrolimus Market?

Tacrolimus Product Type Segment Breakdown
According to Analytical Market Research, the Tacrolimus market by Product Type is segmented into Over-The-Counter (OTC) and Prescription Medications.
Tacrolimus Application Segment Breakdown
According to Analytical Market Research, based on End-use, the market is segmented into Immunosuppression, Dermatitis, and Others.
Tacrolimus End-use Segment Breakdown
According to Analytical Market Research, based on Application the market is segmented into Hospitals, Clinics, and Others.
Tacrolimus Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

Noticeable Players Functioning in The Global Tacrolimus Market Include:

• Astellas Pharma Inc.
• Pfizer Inc.
• GlaxoSmithKline plc
• LEO Pharma A/S
• Dr. Reddy's Laboratories Ltd.
• Glenmark Pharmaceuticals Inc.
• Lupin Pharmaceuticals Inc.
• Panacea Biotec
• Biocon Ltd.
• Novartis AG.

KEY BREAKDOWN: Tacrolimus Market

By Product Type:
• Tablets & Capsules
• Injections
• Others
By Application:
• Immunosuppression
• Dermatitis
• Others.
By End-use:
• Hospitals
• Clinics
• Others
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o U.K.
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

1. Research Methodology
1.1. Global Tacrolimus Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Tacrolimus Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Data Sources
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Tacrolimus Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Tacrolimus Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Product Type, 2023 – 2030
4.3.2.1. Tablets & Capsules
4.3.2.2. Injections
4.3.2.3. Others
4.4. Global Tacrolimus Market Outlook: Application
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
4.4.2.1. Immunosuppression
4.4.2.2. Dermatitis
4.4.2.3. Others.
4.5. Global Tacrolimus Market Outlook: End-use
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
4.5.3. Hospitals
4.5.4. Clinics
4.5.5. Others
5. Global Tacrolimus Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Tacrolimus Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By Application
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030
6.5.1. Tablets & Capsules
6.5.2. Injections
6.5.3. Others
6.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
6.6.1. Immunosuppression
6.6.2. Dermatitis
6.6.3. Others.
6.7. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
6.7.1. Hospitals
6.7.2. Clinics
6.7.3. Others
7. Europe Tacrolimus Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Application
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030
7.5.1. Tablets & Capsules
7.5.2. Injections
7.5.3. Others
7.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
7.6.1. Immunosuppression
7.6.2. Dermatitis
7.6.3. Others.
7.7. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
7.7.1. Hospitals
7.7.2. Clinics
7.7.3. Others
8. Asia Pacific Tacrolimus Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Application
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030
8.5.1. Tablets & Capsules
8.5.2. Injections
8.5.3. Others
8.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
8.6.1. Immunosuppression
8.6.2. Dermatitis
8.6.3. Others.
8.7. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
8.7.1. Hospitals
8.7.2. Clinics
8.7.3. Others
9. Latin America Tacrolimus Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030
9.5.1. Tablets & Capsules
9.5.2. Injections
9.5.3. Others
9.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
9.6.1. Immunosuppression
9.6.2. Dermatitis
9.6.3. Others.
9.7. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
9.7.1. Hospitals
9.7.2. Clinics
9.7.3. Others
10. Middle East & Africa Tacrolimus Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030
10.5.1. Tablets & Capsules
10.5.2. Injections
10.5.3. Others
10.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
10.6.1. Immunosuppression
10.6.2. Dermatitis
10.6.3. Others.
10.7. Market Size (US$ Mn) and Forecast By End-use, 2023 – 2030
10.7.1. Hospitals
10.7.2. Clinics
10.7.3. Others
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Novartis AG (Sandoz).
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Astellas Pharma Inc.
11.3.3. Pfizer Inc.
11.3.4. GlaxoSmithKline plc
11.3.5. LEO Pharma A/S
11.3.6. Dr. Reddy's Laboratories Ltd.
11.3.7. Glenmark Pharmaceuticals Inc.
11.3.8. Lupin Pharmaceuticals Inc.
11.3.9. Panacea Biotec
11.3.10. Biocon Ltd.